To confirm this unexpected observation of BMP4-induced suppression of metastasis even when SMAD4 levels are low, we utilized a second model, the human triple-negative MDA-MB-468 breast cancer line that lacks SMAD4 due to a homozygous deletion [49]. This evidence concerns the gene SMAD4 and breast carcinoma.